Recession fears have eased, boosting investor confidence in the stock market. Albert Edwards warns a market pullback could come without a recession, however. Rising Treasury yields and drying liquidity could hurt stocks with valuations high. Recession fears have largely dissipated since this summer, bolstering investor confidence in a roaring stock market. But Albert Edwards wants investors to remember that equities at historically expensive levels don't need an economic downturn to suffer a pullback. The bearish Societe Generale strategist known for calling the dot-com bubble said in a November 21 client note that the relentless market rally could be due for a reversal — no recession necessary. His argument starts with the fact that valuations are high. There are many ways to measure how pricey a market is, and Edwards shared a few novel examples. For one, US stocks are now three-quarters of the MSCI world index. Then there's the S&P 500's 12-month forward PE relative to its 12-month trailing PE — basically an indicator of how much forward optimism may be getting ahead of itself. It's shown below on the left. The chart on the right side above shows the widely followed Shiller CAPE ratio. By itself, it shows the market is as costly as it was around the top of prior bubbles. But it's also very expensive relative to European stocks, which have historically traded at similar valuation levels to US stocks. The second part of Edwards' argument is that liquidity is drying up in the sense that the Fed is shrinking its balance sheet, which can be bad news when valuations are high. Here's the CrossBorder Capital's Global Liquidity Index, shown in black, which has dipped on a six-week basis. It implies bitcoin, a speculative asset, should be due for a drop in price versus six weeks ago. Rising 10-year Treasury yields could also cause liquidity to dry up, as investors who hold the asset will have taken a loss by selling it. Higher yields also attract capital away from stocks, as Treasurys are risk-free. Edwards said rising yields will eventually put a damper on the stock market, especially with valuations continuing to climb. "To be fair, full blown equity bear markets (-20% or worse) really only ever occur in recessions when both profits and valuations plunge. Alternatively, sharply rising bond yields can cause problems to equities in a high PE environment – such as now," Edwards said. "This is a case of an elastic band stretching to breaking point – the 1987 equity crash would be a good example." He listed a couple more examples: "Just look at the equity euphoria back in 2018, which initially shrugged off rising bond yields – until they didn't. The same happened in 2022. At some point rising bond yields will just as surely begin to hurt equities." Edwards has a fairly poor track record recently, having had a downbeat view on stocks and the economy while the market has soared and the economy has held up. He himself admits this in the November 21 note. So perhaps take his views with a grain of salt. Still, he did foresee the 2000-2002 bear market, and provides, at the very least, logical arguments that are food for thought, as rallies and expansions don't last forever. As Bloomberg Opinion Columnist and former strategist Marcus Ashworth put it last year: "The SocGen strategist's doomster scribblings are a must-read for fund managers — even if he's often wrong."Popular Kmart Christmas product recalled over chemical defectMutual of America Capital Management LLC Has $2.57 Million Holdings in Grid Dynamics Holdings, Inc. (NASDAQ:GDYN)But what if I told you that may not necessarily be the case, and that your favourite discontinued chocolate may be sitting on your local supermarket shelf right now. Well it's true. Chocolate lovers have endured a tough 12 months with major brands including Cadbury and Nestle axing products from their range. Chocolates discontinued in 2024 Some of the chocolates discontinued in the UK so far this year have included: Cadbury Discontinued UK chocolates and sweets (function (d, s, n) { var js, fjs = d.getElementsByTagName(s)[0]; js = d.createElement(s); js.className = n; js.src = "//player.ex.co/player/be9c772c-16dd-4f29-8524-a05d13ea67f6"; fjs.parentNode.insertBefore(js, fjs); js.setAttribute('programmatic', 'true'); js.onload = function () { const playerApi232038 = ExCoPlayer.connect('be9c772c-16dd-4f29-8524-a05d13ea67f6'); playerApi232038.init({ "autoPlay": false, "mute": true, "showAds": true, "playbackMode": "play-in-view", "content": { "playFirst": [ { "title": "Discontinued UK Sweets/Chocolates", "src": "https://large-cdn.ex.co/transformations/production/07e8370e-04f6-4f11-86d9-86c3c15c0e54/720p.mp4" } ], "playlistId": "649b12ab2e5cf6001251de51" }, "sticky": { "mode": "persistent", "closeButton": true, "pauseOnClose": true, "desktop": { "enabled": false, "position": "bottom-right" }, "mobile": { "enabled": false, "position": "upper-small" } }}); }; }(document, 'script', 'exco-player')); Nestle Discontinued chocolates still available in UK stores But although you may think that once chocolates have been discontinued, they are no longer available, that is not always the case. To prove this, I went to local stores including Asda, B&M, Tesco and Home Bargains to see which discontinued chocolates I could find. Here's what I found: Cadbury Dairy Milk Mint Crisp Cadbury's Dairy Milk Mint Crisp chocolate bar returned as part of it's 2024 Christmas range. (Image: Patrick Glover) Cadbury confirmed earlier this year its Dairy Milk Mint Crisp chocolate bar had been discontinued and there were "no plans" to bring it back. However, it appears the company has done a back flip on this decision with the popular chocolate bar reintroduced as part of the company's 2024 Christmas range . You can find Dairy Milk Mint Crisp bars in stores across the UK including at the likes of Asda and Tesco. Caramac Nestle announced that Caramac bars had been discontinued in November 2023 due to falling sales. (Image: Patrick Glover) In November 2023, Nestle revealed it was discontinuing its Caramac and Animal Bars, a decision the company said was made due to falling sales. Caramac was had been a part of the Nestle range for 64 years. But on July 23, Caramac bars made a return to stores across the UK. Nestle said they would be available "while stocks last", but over four months later and they are still on sale across the country including in Asda and B&M. Alongside the bar, there Caramac button sharing bags and a multipacks are also available. Cadbury Dream Marvellous Creations Raspberry Cadbury White chocolate bars were released in the UK in 2019 to replace the previously discontinued Dream bars. (Image: Patrick Glover) Cadbury launched Dream chocolate in the UK back in 2002. But it didn't last long, being discontinued a few years later. In 2019, the confectionary company released Cadbury white as a replacement. But Dream chocolate is still available in other countries - including Australia. And as a result, Cadbury Dream Marvellous Creations Raspberry chocolate bars returned to B&M stores across the country back in October. Cadbury Coins Cadbury coins were discontinued back in 2014, but have returned for the festive season in both 2023 and 2024. (Image: Patrick Glover) Cadbury Coins were discontinued back in 2014. But it appears now they have become a part of it's Christmas range. First appearing on shelves for a limited time over the festive period in 2023, and now back again ahead of Christmas 2024. But you'll need to be quick if you are hoping to get your hands on a bag of Cadbury coins. Because once they're gone you'll have to wait until next Christmas for your next chance. Cadbury Fuse Mini Treats Cadbury Fuse Mini Treats were discontinued in the UK "several years ago", but made a return in select B&M stores across the country recently. Like the Dream chocolate bar, Fuse Mini Treats are still available in other countries, hence how B&M have managed to acquire stock. While I was unable to find any at my local B&M store, despite several attempts, Newfoodsuk was able to secure a packet back in October. Other discontinued chocolates spotted in 2024 A variety of other discontinued chocolates have been spotted in stores across the UK in 2024. These include the likes of Nestle Animal bars (discontinued in 2023) and Milky Way Crispy Rolls (discontinued by Mars Wrigley in 2022). Best places to find discontinued chocolates Big name brands will bring back discontinued chocolates from time to time - like Nestle and Caramac or Cadbury and Dairy Milk Mint Crisp bars - which will mean they will be more readily available, including at major supermarkets (like Tesco and Asda). But, what I have found, is you are more likely to find a discontinued gem in either B&M or Home Bargains. B&M has been particularly good for discontinued chocolates. RECOMMENDED READING: It's also worth keeping an eye out at B&M for different chocolate bars that have come from overseas, that aren't usually available in the UK. The likes of Cherry Ripe (Australia), Dairy Milk Snack (Australia) and Perky Nana (New Zealand) chocolate bars have all been spotted at B&M stores at some point recently, and are popular among chocolate lovers in the UK. So next time you head out to the shops, make sure you keep your eyes peeled for any discontinued chocolates that may be hiding on the shelves.
In his year-end press conference on December 19, Russian President Vladimir Putin reflected on a range of issues, from the ongoing war in Ukraine to Russia’s evolving nuclear doctrine and its foreign policy. Putin acknowledged that, in hindsight, Russia should have prepared more systematically for the invasion of Ukraine in 2022, which he continues to refer to as a “special military operation.” He added that the country should have launched a full-scale invasion earlier, highlighting the lessons learned from the conflict, which has entered its second year. Putin’s statements underscored his belief that Russia was forced to act to protect its sovereignty, particularly in light of what he described as a period leading up to the invasion when the country was at risk of losing its sovereignty. He reflected on how Russia had regained its autonomy since his time in office, contrasting it with the challenges faced during Boris Yeltsin’s presidency 25 years ago. In his view, Russia’s sovereignty had been preserved against overwhelming external pressures. Turning to foreign policy, Putin was asked about the recent developments in Syria, particularly regarding the fall of President Bashar al-Assad’s regime. He insisted that the situation was “complicated,” but not a defeat for Russia, which had supported Assad militarily throughout the conflict. Putin mentioned that he had not yet spoken with the ousted Syrian leader, who fled to Moscow as rebel forces advanced on Damascus, but intended to do so soon. Russia, he said, would continue its talks with Syria’s new leadership to retain strategic military bases on the Mediterranean coast, which could potentially be repurposed for humanitarian efforts. Putin was also questioned about U.S. President-elect Donald Trump, noting that it had been four years since the two leaders last spoke but expressing readiness to meet him again if Trump desired. In a moment of levity, when asked if he was in a weaker position compared to the incoming U.S. President, Putin quipped, quoting Mark Twain: “The rumours of my death are much exaggerated,” which drew laughter from the assembled journalists. On relations with China, Putin asserted that Russia’s ties with its eastern neighbor had reached unprecedented levels. He described the bilateral cooperation between Russia and China as historically unparalleled, with both nations coordinating actions on the world stage. The majority of Putin’s remarks, however, focused on the war in Ukraine, where he claimed Russia was making progress on the frontlines “every day,” describing his troops as “heroes.” He presented a signed flag from Russian marines fighting in the Kursk region as a symbol of their bravery and commitment. He also emphasized the ongoing construction projects in territories seized from Ukraine, citing improvements in infrastructure, particularly in the Luhansk region, which has been under Russian control since 2014. Putin was pressed on the West’s response to Russia’s nuclear posture, specifically its updated nuclear doctrine, which was passed in November. Under this new policy, Russia reserves the right to use nuclear weapons against any nation that launches an attack on it, or its allies, if those nations are backed by nuclear powers. The doctrine, he argued, was a necessary safeguard of Russian sovereignty, and he hinted that the West might not fully appreciate the message behind it. On military technology, Putin highlighted Russia’s newly developed intermediate-range ballistic missile, the Oreshnik, which was used in a November strike on Ukraine. He provocatively suggested that Russia should test the missile’s power by firing it at Ukraine, with the expectation that Ukraine’s air defenses, which rely on U.S.-supplied systems, would try to intercept it. When asked about the missile’s name, Putin jokingly admitted, “Honestly, no idea. No clue.” Throughout the press conference, the theme of “Russian sovereignty” was prevalent, with Putin emphasizing that less reliance on foreign partners—especially due to Western sanctions—was one of the key outcomes of the Ukraine invasion. While he claimed that Russia’s economy was stable, he acknowledged that inflation, at 9.1%, was “alarming,” though he pointed to higher growth rates than countries like Germany. He also discussed the country’s economic challenges, noting that it was increasingly reliant on military production to sustain its economy. On domestic issues, Putin touched on a variety of topics, from the difficulties faced by young people in securing mortgages to the rise in telephone scams. However, his remarks underscored the sense of self-sufficiency he believed Russia had achieved, despite the ongoing hardships. The four-hour press conference, titled “Results of the Year with Vladimir Putin,” was tightly controlled, with Putin answering questions from the public, foreign journalists, and pensioners. It was broadcast live across state TV channels and served as an opportunity for the president to assert his narrative on Russia’s role in global affairs, the economy, and the war in Ukraine. As the country faces a challenging year ahead, Putin’s reflections provide insight into his stance on sovereignty, military power, and Russia’s place in the world.Area Girls Basketball: Rangers take down ranked opponent
Gainers Lytus Technologies Hldgs LYT shares moved upwards by 181.6% to $2.83 during Friday's pre-market session. The company's market cap stands at $5.2 million. Baosheng Media Gr BAOS stock increased by 9.67% to $1.7. The company's market cap stands at $2.6 million. LQR House YHC stock rose 6.91% to $1.7. The company's market cap stands at $12.1 million. Asset Entities ASST shares moved upwards by 6.71% to $0.41. The company's market cap stands at $2.4 million. TuanChe TC stock moved upwards by 6.65% to $1.0. The company's market cap stands at $1.7 million. Losers FingerMotion FNGR stock fell 25.0% to $1.5 during Friday's pre-market session. The market value of their outstanding shares is at $80.7 million. Ucloudlink Group UCL stock fell 12.12% to $1.85. The company's market cap stands at $69.1 million. Scholastic SCHL shares declined by 11.4% to $22.01. The market value of their outstanding shares is at $619.3 million. As per the press release, Q2 earnings came out yesterday. Haoxi Health Technology HAO shares declined by 10.85% to $0.11. The market value of their outstanding shares is at $5.3 million. MultiMetaVerse Holdings MMV shares decreased by 8.57% to $0.57. The market value of their outstanding shares is at $21.2 million. Kuke Music Hldg KUKE shares decreased by 7.7% to $0.36. The company's market cap stands at $14.2 million. See Also: www.benzinga.com/money/best-communication-services-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Thrivent Financial for Lutherans Has $1.66 Million Stake in LyondellBasell Industries (NYSE:LYB)
Sofia will celebrate the holiday season with festive decorations spread across more than 50 locations throughout the city, creating a magical atmosphere for residents and visitors alike. The municipality announced that the city will feature dazzling lights, themed photo spots, Christmas markets, and beautifully adorned Christmas trees. The centerpiece of the festive decorations will be the Christmas trees at key locations. A towering 15-meter tree will stand at Alexander Nevsky Square, set to be illuminated on December 1 during a special ceremony. Meanwhile, on November 30, children will have the chance to participate in a Christmas toy workshop at the square, crafting ornaments to decorate the city. A smaller but equally festive 6-meter tree will be placed in front of the National Palace of Culture, featuring ornaments handmade by children from 199 kindergartens and social services across Sofia. Additionally, a modern-style Christmas tree will enhance the holiday atmosphere at St. Nedelya Square. For those looking to capture memories, themed photo zones will be set up around Sofia. Alexander Nevsky Square will host a decorative truck and a festive box, while a sleigh will offer a charming backdrop in the Largo area. In front of the Ivan Vazov National Theater, the lights will be adorned with fir-tree shapes and large Christmas balls, and the Lotus installation will light up the nearby garden. An illuminated "2025" sign and festively decorated spheres will add a modern touch in front of the National Palace of Culture. The Christmas markets will be another highlight of the celebrations. The German Christmas market in the City Garden will offer traditional treats and gifts, while Sofia Christmas Fest, located near the National Palace of Culture, will combine themed stalls with photo opportunities. The Rila Hotel garden will feature hot drinks and a relaxed festive vibe, and Krasno Selo’s bazaar will bring holiday cheer to the neighborhood. Holiday lights will brighten all districts of Sofia , illuminating key streets, boulevards, and parks. Locations include Sredets District with Graf Ignatiev Street, Tsar Osvoboditel Boulevard, and Borisova Gradina; Oborishte District, featuring Dondukov Boulevard and Moskovska Street; and Triaditsa District with Vitosha Boulevard and South Park. Other decorated areas include Lozenets, Krasna Polyana, Krasno Selo, Vazrazhdane, Novi Iskar, Lyulin, Slatina, and Mladost districts. Adding to the festivities, several trams will be adorned with sparkling lights, spreading holiday joy to passengers as they travel through the city."Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.
NEW YORK (AP) — Remember what you searched for in 2024? Google does. Google released its annual “Year in Search” on Tuesday, rounding up the top trending queries entered into its namesake search engine in 2024. The results show terms that saw the highest spike in traffic compared to last year — ranging from key news events, notably global elections , to the most popular songs, athletes and unforgettable pop-culture moments that people looked up worldwide. Sports — particularly soccer and cricket — dominated Google's overall trending searches in 2024. Copa América topped those search trends globally, followed by the UEFA European Championship and ICC Men's T20 World Cup . Meanwhile, the U.S. election led news-specific searches worldwide. Queries about excessive heat and this year's Olympic Games followed. U.S. President-elect Donald Trump topped searches in Google's people category this year — followed by Catherine, Princess of Wales , U.S. Vice President Kamala Harris and Algerian boxer Imane Khelif , who also led athlete-specific searches. Meanwhile, the late Liam Payne , Toby Keith and O.J. Simpson led search trends among notable individuals who died in 2024. In the world of entertainment, Disney and Pixar's “Inside Out 2” was the top trending movie of the year, while Netflix's “Baby Reindeer” led TV show trends. And Kendrick Lamar’s “Not Like Us” dominated song trends. That's just the tip of the iceberg. Queries for the Olympic village's chocolate muffin , made famous by Norwegian swimmer Henrik Christiansen over the summer games, led Google's global recipe trends this year. The New York Times' “Connections” puzzle topped game searches. And in the U.S., country-specific data shows, many people asked Google about online trends like the word “demure” and “ mob wife aesthetic .” You can find more country-specific lists, and trends from years past , through Google’s “Year in Search” data published online . The California company said it collected 2024 search results from Jan. 1 through Nov. 23 of this year. Google isn't the only one to publish an annual recap or top trends as 2024 draws to a close. Spotify Wrapped , for example, as well as Collins Dictionary and Merriam-Webster’s words of the year, have offered additional reflections for 2024.
Thrivent Financial for Lutherans Increases Stock Holdings in COPT Defense Properties (NYSE:CDP)Dallas Cowboys star guard Zack Martin is doubtful for Sunday's game against the Washington Commanders due to ankle and shoulder injuries. Martin didn't practice at all this week. He also physically struggled during Monday night's loss to the Houston Texas. Martin, who turned 34 on Wednesday, has started all 162 games played in 11 seasons with the Cowboys. He's a nine-time Pro Bowl selection and a seven-time first-team All-Pro. Tight end Jake Ferguson (concussion) and safety Markquese Bell (shoulder) have been ruled out. Neither player practiced this week after being hurt against the Texans. Cornerback DaRon Bland (foot) practiced in full this week and will make his season debut. He was injured in August. Star wideout CeeDee Lamb (back/foot) was a full practice participant on Friday and is good to go. Cornerback Trevon Diggs (groin/knee) and receiver Brandin Cooks (knee) are among six players listed as questionable. The others are offensive tackle Chuma Edoga (toe), guard Tyler Smith (ankle/knee), defensive end Marshawn Kneeland (knee) and linebacker Nick Vigil (foot). --Field Level MediaNone
Shares of Viking Therapeutics, Inc. ( NASDAQ:VKTX – Get Free Report ) were up 2% on Thursday . The company traded as high as $54.73 and last traded at $54.51. Approximately 2,571,782 shares were traded during mid-day trading, a decline of 43% from the average daily volume of 4,522,554 shares. The stock had previously closed at $53.42. Wall Street Analysts Forecast Growth Several equities research analysts recently weighed in on the company. StockNews.com raised Viking Therapeutics to a “sell” rating in a research report on Tuesday, October 15th. Oppenheimer reaffirmed an “outperform” rating and set a $138.00 price objective on shares of Viking Therapeutics in a report on Wednesday, September 25th. HC Wainwright reiterated a “buy” rating and issued a $102.00 target price on shares of Viking Therapeutics in a report on Tuesday. William Blair restated an “outperform” rating on shares of Viking Therapeutics in a report on Wednesday, November 20th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $105.00 price objective on shares of Viking Therapeutics in a research note on Thursday, September 12th. One analyst has rated the stock with a sell rating, ten have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $109.73. Read Our Latest Stock Analysis on VKTX Viking Therapeutics Stock Performance Viking Therapeutics ( NASDAQ:VKTX – Get Free Report ) last issued its earnings results on Wednesday, October 23rd. The biotechnology company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.02. During the same period in the prior year, the firm earned ($0.23) earnings per share. Sell-side analysts anticipate that Viking Therapeutics, Inc. will post -0.98 earnings per share for the current fiscal year. Insider Activity at Viking Therapeutics In related news, Director Lawson Macartney sold 2,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $68.67, for a total value of $137,340.00. Following the sale, the director now owns 47,965 shares of the company’s stock, valued at $3,293,756.55. The trade was a 4.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink . Also, Director J Matthew Singleton sold 10,300 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $69.50, for a total value of $715,850.00. Following the completion of the sale, the director now owns 9,500 shares in the company, valued at $660,250. This trade represents a 52.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders have sold a total of 371,117 shares of company stock valued at $27,140,009 over the last quarter. 4.70% of the stock is owned by company insiders. Institutional Trading of Viking Therapeutics Several large investors have recently added to or reduced their stakes in the company. Blue Trust Inc. acquired a new position in shares of Viking Therapeutics in the 3rd quarter worth approximately $26,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Viking Therapeutics in the second quarter worth $27,000. GAMMA Investing LLC grew its holdings in shares of Viking Therapeutics by 124.6% during the third quarter. GAMMA Investing LLC now owns 438 shares of the biotechnology company’s stock worth $28,000 after purchasing an additional 243 shares during the last quarter. Gilliland Jeter Wealth Management LLC acquired a new stake in shares of Viking Therapeutics in the third quarter valued at $32,000. Finally, Stone House Investment Management LLC raised its holdings in shares of Viking Therapeutics by 66.7% in the third quarter. Stone House Investment Management LLC now owns 500 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 200 shares during the last quarter. 76.03% of the stock is owned by institutional investors. About Viking Therapeutics ( Get Free Report ) Viking Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. Featured Stories Receive News & Ratings for Viking Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viking Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .
A lead organization monitoring for food crises around the world withdrew a new report this week warning of imminent famine in north Gaza under what it called Israel's “near-total blockade,” after the U.S. asked for its retraction, U.S. officials told The Associated Press. The move follows public criticism of the report from the U.S. ambassador to Israel. The rare public challenge from the Biden administration of the work of the U.S.-funded Famine Early Warning System, which is meant to reflect the data-driven analysis of unbiased experts, drew accusations from aid and human-rights figures of possible U.S. political interference. A finding of famine would be a public rebuke of Israel, which has insisted that its 15-month war in Gaza is aimed against the Hamas militant group and not against its civilian population. > Watch NBC Bay Area News 📺 Streaming free 24/7 U.S. ambassador to Israel Jacob Lew earlier this week called the warning by the internationally recognized group inaccurate and “irresponsible." Lew and the U.S. Agency for International Development, which funds the monitoring group, both said the findings failed to properly account for rapidly changing circumstances in north Gaza. Humanitarian and human rights officials expressed fear of U.S. political interference in the world's monitoring system for famines. The U.S. Embassy in Israel and the State Department declined comment. FEWS officials did not respond to questions. “We work day and night with the U.N. and our Israeli partners to meet humanitarian needs — which are great — and relying on inaccurate data is irresponsible,” Lew said Tuesday. USAID confirmed to the AP that it had asked the famine-monitoring organization to withdraw its stepped-up warning issued in a report dated Monday. The report did not appear among the top updates on the group's website Thursday, but the link to it remained active. The dispute points in part to the difficulty of assessing the extent of starvation in largely isolated northern Gaza. Thousands in recent weeks have fled an intensified Israeli military crackdown that aid groups say has allowed delivery of only a dozen trucks of food and water since roughly October. FEWS Net said in its withdrawn report that unless Israel changes its policy, it expects the number of people dying of starvation and related ailments in north Gaza to reach between two and 15 per day sometime between January and March. The internationally recognized mortality threshold for famine is two or more deaths a day per 10,000 people. FEWS was created by the U.S. development agency in the 1980s and is still funded by it. But it is intended to provide independent, neutral and data-driven assessments of hunger crises, including in war zones. Its findings help guide decisions on aid by the U.S. and other governments and agencies around the world. A spokesman for Israel's foreign ministry, Oren Marmorstein, welcomed the U.S. ambassador's public challenge of the famine warning. “FEWS NET - Stop spreading these lies!” Marmorstein said on X. In challenging the findings publicly, the U.S. ambassador "leveraged his political power to undermine the work of this expert agency,” said Scott Paul, a senior manager at the Oxfam America humanitarian nonprofit. Paul stressed that he was not weighing in on the accuracy of the data or methodology of the report. “The whole point of creating FEWS is to have a group of experts make assessments about imminent famine that are untainted by political considerations,” said Kenneth Roth, former executive director of Human Rights Watch and now a visiting professor in international affairs at Princeton University. “It sure looks like USAID is allowing political considerations -- the Biden administration’s worry about funding Israel’s starvation strategy -- to interfere." Israel says it has been operating in recent months against Hamas militants still active in northern Gaza. It says the vast majority of the area’s residents have fled and relocated to Gaza City, where most aid destined for the north is delivered. But some critics, including a former defense minister, have accused Israel of carrying out ethnic cleansing in Gaza’s far north, near the Israeli border. North Gaza has been one of the areas hardest-hit by fighting and Israel’s restrictions on aid throughout its war with Hamas militants. Global famine monitors and U.N. and U.S. officials have warned repeatedly of the imminent risk of malnutrition and deaths from starvation hitting famine levels. International officials say Israel last summer increased the amount of aid it was admitting there, under U.S. pressure. The U.S. and U.N. have said Gaza’s people as a whole need between 350 and 500 trucks a day of food and other vital needs. But the U.N. and aid groups say Israel recently has again blocked almost all aid to that part of Gaza. Cindy McCain, the American head of the U.N. World Food Program, called earlier this month for political pressure to get food flowing to Palestinians there. Israel says it places no restrictions on aid entering Gaza and that hundreds of truckloads of goods are piled up at Gaza’s crossings and accused international aid agencies of failing to deliver the supplies. The U.N. and other aid groups say Israeli restrictions, ongoing combat, looting and insufficient security by Israeli troops make it impossible to deliver aid effectively. Lew, the U.S. ambassador, said the famine warning was based on “outdated and inaccurate” data. He pointed to uncertainty over how many of the 65,000-75,000 people remaining in northern Gaza had fled in recent weeks, saying that skewed the findings. FEWS said in its report that its famine assessment holds even if as few as 10,000 people remain. USAID in its statement to AP said it had reviewed the report before it became public, and noted “discrepancies” in population estimates and some other data. The U.S. agency had asked the famine warning group to address those uncertainties and be clear in its final report to reflect how those uncertainties affected its predictions of famine, it said. “This was relayed before Ambassador Lew’s statement,” USAID said in a statement. “FEWS NET did not resolve any of these concerns and published in spite of these technical comments and a request for substantive engagement before publication. As such, USAID asked to retract the report.” Roth criticized the U.S. challenge of the report in light of the gravity of the crisis there. “This quibbling over the number of people desperate for food seems a politicized diversion from the fact that the Israeli government is blocking virtually all food from getting in,” he said, adding that “the Biden administration seems to be closing its eyes to that reality, but putting its head in the sand won’t feed anyone.” The U.S., Israel’s main backer, provided a record amount of military support in the first year of the war. At the same time, the Biden administration repeatedly urged Israel to allow more access to aid deliveries in Gaza overall, and warned that failing to do so could trigger U.S. restrictions on military support. The administration recently said Israel was making improvements and declined to carry out its threat of restrictions. Military support for Israel’s war in Gaza is politically charged in the U.S., with Republicans and some Democrats staunchly opposed any effort to limit U.S. support over the suffering of Palestinian civilians trapped in the conflict. The Biden administration’s reluctance to do more to press Israel for improved treatment of civilians undercut support for Democrats in last month’s elections. ___ Sam Mednick and Josef Federman in Jerusalem contributed to this report.Foundations Investment Advisors LLC Purchases 16,392 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Manalo meets Pope Francis, to join G7 ministers in ItalyElon Musk: "We Should Unwind" The NGO Industry
LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule, 5550(a)(2). The Company’s security will continue to be listed and traded on The Nasdaq Stock Market and this matter is now closed. Renovaro previously received a notification letter from the Nasdaq Listing Qualifications Department on September 12, 2024, notifying the Company that, over the previous 30 consecutive business days, the closing bid price of the Company’s common stock had been below the minimum of $1.00 per share required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). About Renovaro Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and Renovaro Cube. Renovaro Cube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. Renovaro Cube intervenes at a stage where potential therapy can be most effective. Renovaro Cube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in disease agnostic decision support. Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. Investor Relations Chris Tyson Executive Vice President MZ Group - MZ North America 949-491-8235 RENB@mzgroup.us www.mzgroup.us For media inquiries, please contact: karen@Renovaro Cube.com and STarsh@Renovarogroup.com
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |